Cancer and Metastasis Reviews

Papers
(The H4-Index of Cancer and Metastasis Reviews is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Editorial Expression of Concern: Targeting microRNAs as a promising anti-cancer therapeutic strategy against traffic-related air pollution-mediated lung cancer216
Immunotherapy for leptomeningeal disease from solid tumors: current clinical outcomes and future opportunities148
The impact of tumor microenvironment: unraveling the role of physical cues in breast cancer progression111
Clonal tracking in cancer and metastasis102
CAR T-cell therapy for B-cell lymphomas: outcomes and resistance mechanisms80
New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions78
The functions and modifications of tRNA-derived small RNAs in cancer biology77
Obesity and cancer70
Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective67
Regulation of dormancy during tumor dissemination: the role of the ECM66
Targeting lipid metabolism in cancer: neuroblastoma52
The paradoxical role of inositol in cancer: a consequence of the metabolic state of a tumor50
CAR T-cell therapy to treat multiple myeloma: current state and future directions49
Progression and metastasis of small cell lung carcinoma: the role of the PI3K/Akt/mTOR pathway and metabolic alterations49
Cell-cell interactions mediating primary and metastatic breast cancer dormancy48
Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?48
Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives48
The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer48
p73 isoforms meet evolution of metastasis46
KISS1 metastasis suppressor in tumor dormancy: a potential therapeutic target for metastatic cancers?41
Healthcare disparities, screening, and molecular testing in the changing landscape of non–small cell lung cancer in the United States: a review40
TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond40
A multidisciplinary perspective on the complex interactions between sleep, circadian, and metabolic disruption in cancer patients39
Preface37
Targeting microRNAs as a promising anti-cancer therapeutic strategy against traffic-related air pollution-mediated lung cancer36
Biography—Mathieu Boissan, Pharm.D., Ph.D36
LGR5: An emerging therapeutic target for cancer metastasis and chemotherapy resistance34
Neuropeptide Y in cancer—biological functions and potential clinical implications33
How circulating tumor cluster biology contributes to the metastatic cascade: from invasion to dissemination and dormancy31
Role of Neuropilin-2-mediated signaling axis in cancer progression and therapy resistance31
Biographies31
Biographies31
0.035259962081909